Comera Life Sciences Inc... (CMRAW)
NASDAQ: CMRAW
· Real-Time Price · USD
0.02
null (null%)
At close: Sep 17, 2024, 10:00 PM
Comera Life Sciences Income Statement
Financials in USD. Fiscal
year is
undefined.
| Fiscal Year | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 136.31K | 315.06K | 392.92K | 156.12K | 234.92K | 146.73K | 95.33K | 73.33K | 87.77K | 70.92K | 87.81K |
Cost of Revenue | 41.96K | 56.04K | 116.52K | 50.36K | 60.96K | 54.54K | 44.52K | 38.94K | 48.36K | 57.57K | 16.14K |
Gross Profit | 94.35K | 259.01K | 276.4K | 105.76K | 173.96K | 92.18K | 50.81K | 34.4K | 39.4K | 13.35K | 71.67K |
Operating Income | -2.16M | -1.48M | -2.5M | -3.01M | -2.54M | -3.97M | -2.45M | -2.02M | -913.7K | -1.9M | -693.8K |
Interest Income | n/a | 3.98K | 7.62K | 7.62K | 12.7K | n/a | n/a | n/a | n/a | n/a | 189.00 |
Pretax Income | -2.15M | -1.41M | -2.48M | -2.96M | -3.08M | -9.09M | -2.88M | -2.02M | -913.7K | -1.98M | -533.4K |
Net Income | -2.15M | -1.41M | -77.77M | -2.92M | -3.62M | -14.2M | -3.31M | -2.02M | -913.7K | -1.98M | -533.4K |
Selling & General & Admin | 1.89M | 1.5M | 2.43M | 2.63M | 2.31M | 3.7M | 2.02M | 1.57M | 689.48K | 1.24M | 446.4K |
Research & Development | 366.01K | 235.7K | 343.7K | 489.26K | 394.8K | 368.55K | 487.22K | 490.34K | 263.62K | 679.63K | 319.07K |
Other Expenses | n/a | n/a | n/a | n/a | -1.03M | n/a | -426.67K | n/a | n/a | -76.74K | n/a |
Operating Expenses | 2.25M | 1.74M | 2.78M | 3.11M | 2.71M | 4.07M | 2.5M | 2.06M | 953.1K | 1.92M | 604.89K |
Interest Expense | 5.96K | 3.98K | 7.62K | 7.62K | 12.7K | 5.11M | 77.00 | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 2.29M | 1.8M | 2.89M | 3.17M | 2.77M | 4.12M | 2.55M | 2.1M | 1M | 1.97M | 621.03K |
Income Tax Expense | n/a | 3.98K | 75.29M | -46.49K | 541.45K | 5.11M | 426.74K | -83.85K | 3.39M | -97.18K | n/a |
Shares Outstanding (Basic) | 23.11M | 19.15M | 19.03M | 10.45M | 16.02M | 8.14M | 19.09M | 13.24M | 19.09M | 19.09M | 11.43M |
Shares Outstanding (Diluted) | 23.11M | 19.15M | 19.03M | 10.45M | 16.02M | 8.14M | 19.09M | 13.24M | 19.09M | 19.09M | 11.43M |
EPS (Basic) | -0.1 | -0.07 | -4.09 | -0.28 | -0.23 | -1.74 | -0.17 | -0.15 | -0.05 | -0.1 | -0.05 |
EPS (Diluted) | -0.1 | -0.07 | -4.09 | -0.28 | -0.23 | -1.74 | -0.17 | -0.15 | -0.05 | -0.1 | -0.05 |
EBITDA | -2.12M | -1.38M | -2.44M | -2.93M | -3.04M | -9.09M | -2.43M | -2M | -894.54K | -1.98M | 4.25M |
EBIT | -2.15M | -1.41M | -2.47M | -2.95M | -3.06M | -9.09M | -2.88M | -2.11M | -913.7K | -1.98M | 4.25M |
Depreciation & Amortization | 24.4K | 26.25K | 29.67K | 25.17K | 25.2K | 21.62K | 24.77K | 24.21K | 19.16K | 20.44K | 22.33K |